Gene Therapy Trials Dominate Rare Disease Clinical Development
Market Overview
The Rare Disease Clinical Trials Market is significantly shaped by gene therapy development, as many rare diseases result from single-gene mutations amenable to genetic correction. Gene therapy offers the promise of definitive treatment rather than chronic symptom management, fundamentally altering the therapeutic paradigm for conditions previously lacking effective options. The...
0 Comments
0 Shares